Equities

Svas Biosana SpA

SVS:MIL

Svas Biosana SpA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)7.95
  • Today's Change-0.10 / -1.24%
  • Shares traded19.39k
  • 1 Year change-2.33%
  • Beta--
Data delayed at least 15 minutes, as of May 23 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Svas Biosana Srl is an Italy-based company, which manufactures and markets medical devices and pharmaceutical products. The Company consists of four divisions namely: Farmex division, manufactures range of gauze and cotton made products; Medical division, provides suction line, infusion line, and custom packs; Svas division, provides own brand products, specialities, galenic solutions and disposables; and Harvest division, provides electromedical equipments, after-sales technical services. The Company is the subsidiary of Svas group. Test Data.

  • Revenue in EUR (TTM)118.28m
  • Net income in EUR5.12m
  • Incorporated1992
  • Employees323.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Seyitler Kimya Sanayi AS4.06m1.06m26.66m63.0025.055.7023.306.570.37090.37091.411.630.7141.737.011,836,392.0018.7336.2022.3544.0238.1239.8626.2343.893.38--0.13190.0084.4045.46193.51107.1230.39--
Biocartis Group NV60.61m-67.87m27.24m526.00------0.4493-0.9993-0.99930.8171-0.57480.55481.563.31115,231.90-62.13-34.35-84.71-40.3851.4040.84-111.97-145.711.60-2.551.55--19.0822.368.52---14.81--
IMD International Medical Devices SpA38.01m2.22m27.35m116.0012.081.258.870.71970.12840.12842.191.24------327,653.90--------27.27--6.45--1.59--0.0638---9.07---24.35------
Micropos Medical AB (publ)152.48k-2.04m27.85m9.00--12.59--182.62-0.258-0.2580.01490.16920.05290.09990.7758221,497.50-70.97-64.24-89.99-82.2774.48114.76-1,340.85-767.574.04--0.0146--50.235.94-26.57------
Belluscura PLC1.11m-9.24m29.55m24.00--1.04--26.59-0.0636-0.06360.00770.14610.04450.21970.309939,407.39-36.98-35.98-40.59-39.17-32.24-40.01-831.69-838.024.17-3.430.00--232.6231.09-56.38--30.90--
Boule Diagnostics AB49.57m2.32m33.42m233.0014.560.77987.060.67420.68680.686814.7912.820.73784.353.532,526,443.003.441.674.732.4043.7343.504.672.041.054.770.263842.244.246.1396.24-9.45-9.74--
Karolinska Development AB166.68k2.89m36.28m8.0012.650.34112.23217.660.12450.12450.00724.620.0016--1.66242,125.002.713.372.733.83----1,734.951,466.36----0.00230.00-12.43-8.10106.11-29.31----
Substrate Artificial Inteligence SA8.61m-8.73m44.47m17.00--0.4947--5.17-0.2986-0.29860.27180.32220.2526-4.403.31506,400.00-24.84---32.78--127.29---98.33--0.7159-6.080.2089--174.53--42.10------
Svas Biosana SpA118.28m5.12m45.08m323.008.430.73244.440.38110.95490.954922.0410.990.75862.862.94366,204.303.292.725.404.7224.4428.124.333.781.415.130.5324--21.6611.3443.5221.7613.33--
Modulight Oyj-100.00bn-100.00bn46.03m70.00--0.8548----------1.26-----------8.39---9.10--114.69---56.816.11--0.1004---12.48-8.20-38.69--63.60--
BrainCool AB (publ)2.51m-4.91m50.15m22.00--4.80--20.00-0.2848-0.28480.14650.47920.24182.093.321,214,417.00-47.34-47.14-56.18-70.16-50.61-149.77-195.75-391.450.7253-7.340.00--32.0678.35-34.34---11.63--
Novacyt SA9.25m-29.72m51.75m222.00--0.4103--5.60-0.4209-0.42220.1311.790.05281.330.262241,660.82-16.9617.69-20.7123.8243.2162.82-321.4023.874.98-79.020.00360.00-77.2813.49-269.46---13.46--
Bioretec Oy3.91m-3.79m53.89m37.00--6.29--13.79-0.1984-0.19840.20470.42130.55241.463.68105,594.60-53.58-67.11-65.75-97.6069.8570.97-96.98-134.054.86-4.020.0754--32.7719.77-56.82------
Affluent Medical SAS0.00-15.65m55.68m52.00---------0.5828-0.58280.00-----------------------------23.85---------2.80------
Senzime AB (publ)3.49m-11.30m57.12m52.00--2.24--16.35-1.30-1.300.39022.950.10451.345.80---33.80-35.69-35.58-38.0026.75-20.59-323.45-558.685.85--0.0308--154.7761.90-1.09---3.69--
Visiomed Group SA13.71m902.00k59.90m94.000.12702.4810.814.371.601.600.03830.08190.37722.409.07145,808.502.48-29.882.84-57.1994.2451.886.57-59.421.710.21270.2426---5.129.42117.09--27.51--
Data as of May 23 2024. Currency figures normalised to Svas Biosana SpA's reporting currency: Euro EUR

Institutional shareholders

10.12%Per cent of shares held by top holders
HolderShares% Held
Lemanik Asset Management SAas of 31 Dec 2021175.83k3.14%
AcomeA SGR SpAas of 30 Jun 2023123.80k2.21%
Mediolanum Gestione Fondi SGRpAas of 29 Dec 202372.00k1.29%
MC Square SAas of 30 Jun 202355.90k1.00%
CARTHESIO SAas of 30 Jun 202353.00k0.95%
Kairos Partners SGR SpAas of 30 Jun 202326.28k0.47%
Banca del Sempione SAas of 31 Dec 202320.00k0.36%
Lemanik Invest SAas of 30 Jun 202219.60k0.35%
Sumus Capital SAas of 29 Apr 202416.00k0.29%
Olympia Wealth Management Ltd.as of 30 Jun 20234.20k0.08%
More ▼
Data from 30 Jun 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.